Guidance for medicine developers and companies on COVID-19
Published: 29/6/2020
EMA encourages medicine developers and pharmaceutical companies who are working on medications and vaccines in regard to COVID-19
European Medicines Agency (EMA) has just released a new guidance directed to developers and pharma companies which aim for the development of COVID-19 vaccines and medicines. The purpose is to optimize the approval time, and how regulatory challenges arising from the pandemic should be addressed.